A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
The Affordable Care Act and Cancer Care for Young Adults.
Xuesong Han,Ahmedin Jemal +1 more
TL;DR: Current literature shows that the ACA increased insurance rate and cancer diagnosis at early stage for young adults and there is also evidence of the ACA's positive effects on initiation and completion of human papillomavirus vaccination and receipt of fertility-sparing treatment for cervical cancer among young women.
Journal ArticleDOI
Prostate cancer disease severity and country of origin among black men in the United States.
TL;DR: Similar Gleason score among US-born, African and Caribbean-born black men were observed, and future more detailed studies are needed to elucidate if these similarities are a result of similar early detection practices or shared risk factors.
Journal ArticleDOI
Reply from Authors re: Lambertus A. Kiemeney. The Global Risk of Bladder Cancer: Let's Just Do Something About It! Eur Urol 2014;66:74–5
TL;DR: Commentary on the study plays down the importance of descriptive epidemiology in identification of new risk factors, including its descriptive nature, and the use of estimated country-specific rates in the absence of registry data.
Journal ArticleDOI
Association of Cigarette Sales With Comprehensive Menthol Flavor Ban in Massachusetts.
Samuel Asare,Anuja Majmundar,J. Lee Westmaas,Priti Bandi,Zheng Xue,Ahmedin Jemal,Nigar Nargis +6 more
TL;DR: The authors used cookies to enhance the experience of our website. By continuing to use our site, or clicking "continue," you are agreeing to our Cookie Policy | Continue  Â
Journal Article
Insurance Status and Cancer Stage at Diagnosis Prior to the Affordable Care Act in the United States.
TL;DR: Uninsured or Medicaid patients had a higher risk of being diagnosed with advanced stage (III/IV) than privately insured patients for most cancer types, with the associations most prominent for diseases that can potentially be detected early by either symptom assessment or screening services.